Market OverviewThe global cell and gene therapy market is undergoing rapid and transformative growth, reflecting its increasing importance in modern healthcare.The market is projected to expand at a ...
6d
Medicaid tries new approach with sickle cell: Companies only get paid if costly gene therapies work
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting ...
Company expects up to six-month review period per FDA guidelines New longer-term clinical data demonstrating durable positive brain biochemical ...
Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa using AAV-based delivery. The trial is a collaboration with Cleveland Clinic ...
Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced an upgrade to its Viral Clearance ...
Gene Expression Data Show Direct Impact on the Core Biology of IPF ...
Like many life sciences outfits undergoing a restructuring, Charles River Laboratories is balancing layoffs and a business ...
Services Market OverviewThe global contract research organization services market is poised to register steady growth at an estimated rate of around 9% over the next five years, reflecting the ...
Is Obesity Genetic or Environmental? Get All the Details This article was reviewed by Lynn Marie Morski, MD, JD. Key ...
Multiple Independent Molecular Signals Converge to Validate GRI-0621 as a Potential Disease-Modifying Therapy LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or ...
The issuer is solely responsible for the content of this announcement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results